| 证券代码 | STDY.O |
| 证券名称 | SteadyMed Ltd |
| 证券类型 | 美股 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | 主板 |
| 发行方式 | 公开发售 |
| 首发上市日 | 2015-03-20 |
| 首发价格(元) | 8.5 USD |
| 首发数量(股) | 4700000 |
| 首发募资额(元) | 39,950,000.00 USD |
| 首发主承销商 | RBC Capital Markets, LLC,Wells Fargo Securities, LLC |
| 货币单位 | USD |
| 公司名称 | SteadyMed Ltd. |
| 注册地址 | 以色列 |
| 办公地址 | 5 Oppenheimer Street, Rehovot, Israel |
| 成立日期 | 2005-06-15 |
| 董事会主席 | - |
| 公司属地 | Israel 以色列 |
| 公司网址 | www.steadymed.com |
| 电话 | +972 (3) 644-9556 |
| 传真 | +972 (3) 644-9558 |
| 公司简介 | SteadyMed Ltd. is a Specialty Pharmaceutical Company. SteadyMed leverages its PatchPump platform to develop its own therapeutic portfolio and partners to optimize the delivery of high volume (greater than two mL), high value, small molecule or biologic drugs. The company's family of PatchPumps can be customized to deliver liquid drugs, including biologics, with a wide range of volumes and viscosities, in a consistent and controllable manner. SteadyMed aspires to redefine the parenteral therapeutics experience for patients dependent upon large doses of intravenous and subcutaneous medications: Extending the limits of parenteral therapeutics to restore freedom, joy and dignity to patients’ lives. |